Riskpilot← Back to searchSign inGet full accessDr. Abdulnour Estetik AB
ABActiveOrg 5592965726Ägostigen 14Business and other management consultancy activities · NACE 7020Est. 20210 employees
Revenue 2025
SEK 104K
-58% vs 2024
EBITDA margin
75.6%
-60% vs 2024
Equity ratio
89.0%
Financial strength
Net profit 2025
SEK 164K
+42% vs 2024
| Revenue | SEK 104K | -58% |
| EBITDA | SEK 79K | -60% |
| Net profit | SEK 164K | +42% |
| Total assets | SEK 359K | -42% |
| Equity | SEK 319K | -10% |
| Employees | 0 | — |
Legal name
Dr. Abdulnour Estetik AB
Org number
5592965726
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
14 januari 2021
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva en skönhetsklinik som genomför estetiska behandlingar samt injektionsbehandlingar i form av fillers och botox. Bolaget skall förvalta värdepapper samt förvalta fast och lös egendom och därmed förenlig verksamhet.
Address
Ägostigen 14
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 366 | 251 | 104 |
| Staff expenses | — | −0 | −0 | −0 | −0 |
| EBITDA | −11 | −3 | 336 | 196 | 79 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −11 | −3 | 336 | 196 | 79 |
| Net financials | — | 0 | −0 | 0 | −2 |
| Profit before tax | −11 | −3 | 256 | 147 | 207 |
| Tax | −0 | — | −52 | −31 | −44 |
| Net profit | −11 | −3 | 204 | 116 | 164 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 39 | 36 | 454 | 614 | 359 |
| Equity | 39 | 36 | 240 | 355 | 319 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 0 | — | 134 | 129 | 40 |
| Total debt | — | — | 134 | 129 | 40 |
EBITDA margin
75.6%
This company
15.8%
Market median
+378% vs market
20212025
Equity ratio
89.0%
This company
38.2%
Market median
+133% vs market
20212025
Return on equity
51.3%
This company
18.4%
Market median
+179% vs market
20212025
Net profit margin
157.2%
This company
8.1%
Market median
+1841% vs market
20212025
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
20212025
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (4) | ||
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr. Abdulnour Estetik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Afram Abdulnour | Board of Directors | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Rabi Abdulnour | Deputy Board Member | 0 companies |